Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in Northeastern Brazil

Ophthalmic Epidemiology

Volumn 11, Issue 4, 2004, Pages 301-317

  De Amorim Garcia, Carlos Alexandre ^a   Oréfice, Fernando ^b   De Oliveira Lyra, Clélia ^a   Bezerra Gomes, Alexandre ^a   França, Mardone ^a   De Amorim Garcia Filho, Carlos Alexandre ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Brazil; Ocular toxoplasmosis; Risk factors; Socioeconomic factors; Toxoplasmosis prevalence; Water pollution

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEMATOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEROLOGY; SEROPREVALENCE; SOCIOECONOMICS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; BRAZIL; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; FUNDUS OCULI; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; TOXOPLASMOSIS, OCULAR;

EID: 9644308025     PISSN: 09286586     EISSN: None     Source Type: Journal    
DOI: 10.1080/09286580490515170     Document Type: Article

References (46)

1. Oréfice F. Uveíte: Clínica & Cirúrgica: Atlas e Texto. Rio de Janeiro: Cultura Médica, 2000.
2. Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;154(4): 357-365.
3. Gibson GL, Coleman N. The prevalence of toxoplasma antibodies in Guatemala and Costa Rica. Am J Trop Med Hyg. 1958;7:334-338.
4. Feldman HA. Epidemiology of Toxoplasma infection. Epidemiol Rev. 1982;4:204-213.
5. Coura AJR, Willcox HPF, Albuquerque BC, et al. Aspectos epidemiológicos, sociais e sanitários em áreas do Médio Solimões. I - Estudo das localidades de São Francisco do Laranjal, Aranaí e São Lázaro do Surubim, município de Coari, Amazonas. Acad Nac Med. 1993;153(3):122-126.
6. Rey LC, Ramalho IL. Seroprevalence of toxoplasmosis in Fortaleza-Ceará, Brazil. Rev Inst Med Trop São Paulo. 1999;41(3): 171-174.
7. Souza WJ, Coutinho SG, Lopes CWG, et al. Epidemiological aspects of toxoplasmosis in school children residing in localities with urban or rural characteristics within the city of Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 1987;82(4):475-482.
8. Cantos GA, Prando MD, Siqueira MV, Teixeira RM. Toxoplasmose: ocorrência de anticorpos anti-Toxoplasma gondii e diagnóstico. Rev Inst Ciênci Saúde. 1999;17(1): 7-14.
9. Garcia JL, Navarro IT, Ogawa L, et al. Seroepidemiology of toxoplasmosis and ocular evaluation by Amsler grid in patients from the rural area treated at the Jaguapita county health center, Parana State, Brazil. Rev Soc Bras Med Trop. 1999;32(6):671-676.
10. Araújo IF, Sant'anna B, Hyakutake S. Prevalência de anticorpos anti-Toxoplasma gondii em doadores de sangue de Natal (RN). Rev Farm Bioqim Univ S. Paulo. 1975;13(2): 417-425.
11. Silveira CAM. Toxoplasmose: Dúvidas e Controvérsias. Erechim/RS: Editera FAPES, 2000.
12. Jenum PA, Kapperud G, Stray-Pedersen B, et al. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect. 1998;120:87-92.
13. Amato Neto V, Medeiros EAS, Levi GC, Duarte MIS. Toxoplasmose. São Paulo: Sarvier, 1995.
14. Díaz-Suárez O, Parra AM, Araujo-Fernández M. Seroepidemiology of toxoplasmosis in a marginal community of the Municipality of Maracaibo, Zulia State, Venezuela. Invest Clin. 2001;42(2): 107-121.
15. Ihoshi N, Gianella A. Toxoplasmosis en un grupo de estudiantes de Santa Cruz de la Sierra. Bol Cientif de CENETROP. 1997;XVI:46-48.
16. Chacin-Bonilla L, Sanchez-Chavez Y, Monsalve F, Estevez J. Seroepidemiology of toxoplasmosis in Amerindians from Western Venezuela. Am J Trop Med Hyg. 2001;65(2):131-135.
17. Cook AJ, Gilbert RE, Buffolano W. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. Br Med J. 2000;321:142-147.
18. Sanchez RM, Sanchez RM, Hernandez MS, Carvajales AF. Aspectos seroepidemiologicos de la toxoplasmosis en 2 municipios de la Provincia de Ciego de Avila. Septiembre 1985. Rev Cubana Med Trop. 1989;41(2):214-225.
19. Baril L, Ancelle T, Goulet V. Risk factors for toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999;31:305-309.
20. Bahia-Oliveira LMG, Jones JL, Azevedo-Silva J, et al. Highly endemic, waterborne toxoplasmosis in North Rio de Janeiro State, Brazil. Emerg Infect Dis. 2003;9(1): 55-62.
21. Fan CK, Su KE, Wu GH, Chiou HY. Seroepidemiology of Toxoplasma gondii infection among two mountain aboriginal populations and southeast Asian laborers in Taiwan. J Parasitol. 2002;88(2): 411-414.
22. Guzmán A, Bautista I, Grassais A, et al. Prevalencia de anticuerpos para Toxoplasma gondii en adolescentes femeninas de estratos socio-económicos diferentes. Arch Dominicana Pediatr. 1987;23(3): S/135-S/137.
23. Aramine JJ, Stephen C, Dubey UP, et al. Potential contamination of drinking water with Toxoplasma gondii oocysts. Epidemiol Infect. 1999;122:305-315.
24. Beniz J. Toxoplasmose ocular adquirida (relato de 3 casos). Arq Bras Oftalmol. 1993;56:134-136.
25. Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 1996;23:277-282.
26. Burnett AJ, Shortt SG, Isaac-Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105(6):1032-1037.
27. Fernandes LC, Oréfice F. Aspectos clínicos e epidemiológicos das uveítes em servĩo de referência em Belo Horizonte 1970-1993, Parte I. Rev Bras Oftalmol. 1996;55:569-578.
28. Garcia CAA, Gomes AHB, Barbosa MFA, et al. Aspectos clínicos e epidemiológicos das uveítes em Natal - RN. Rev Bras Oftalmol. 2002;61(2):121-129.
29. Smith RE, Ganley JP. Ophthalmic survey of a community. I. Abnormalities of the ocular fundi. Am J Ophthalmol. 1972;74:1126.
30. Arias ML, Chinchilla M, Reyes LL, Linder E. Seroepidemiology of toxoplasmosis in humans: possible transmission routes in Costa Rica. Rev Biol Trop. 1990;44(2A): 377-381.
31. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med. 1997:43:93-97.
32. Duong TH, Dufillot D, Martz M, et al. Etude sero-epidemiologique de la toxoplasmose a Libreville, Gabon. Ann Soc Belg Med Trop. 1992;72(4): 289-293.
33. López R, Pérez X, Collazo JE, Acosta C. Anticuerpo anti-toxoplasma gondii en niños cubanos. Biomedica. 1993;13(4):183-186.
34. Catár G, Giboda M, Gutvirth J, Hongvanthong B. Seroepidemiological study of toxoplasmosis in Laos. Southeast Asian J Trop Med Publ Health. 1992;23(3):491-492.
35. Pereira LH, Staudt M, Tanner CE, Embil JA. Exposure to Toxoplasma gondii and cat ownership in Nova Scotia. Pediatrics. 1992:89(6 Pt 2):1169-1172.
36. Barbier D, Ancelle T, Martin-Bouyer G. Seroepidemiological survey of toxoplasmosis in La Guadeloupe, French West Indies. Am J Trop Med Hyg. 1983;32(5):935-942.
37. Couver J, Desmont G. Les modes de propagation de la toxoplasmose humaine. Arch Franc Pediatr. 1965;18:1026-1032.
38. Sadaruddin A, Agha F, Ghafoor A. Seroepidemiology of Toxoplasma gondii infection in young school children in Islamabad. J Pak Med Assoc. 1991;41(6):131-134.
39. Velasco-Castrejon O, Salvatierra-Izaba B, Valdespino JL, et al. Seroepidemiology of toxoplasmosis in Mexico. Salud Publ Mex. 1992;34(2):222-229.
40. Anderson KP, Atlas E, Ahern MJ, Weisbrot IM. Central nervous system toxoplasmosis in homosexual men. Am J Med. 1983;75:877-881.
41. Hakim SL, Radzan T, Nazman M. Distribution of anti-Toxoplasma gondii antibodies among Orang Asli (aborigines) in Peninsular Malaysia. Southeast Asian J Trop Med Publ Health. 1994;25(3):485-489.
42. Rocha OM, Carvalho MG, Silva MBS, Lignani C. Remanescentes Xakriabá em Minas Gerais: Prevalência da doença de Chagas e toxoplasmose e avaliação do quadro hematológico dos infectados. Rev Farm Bioquím. 1987;8:19-27.
43. Koppe JG, Loewer-Sieger DH, Roever BH. Results of 20-year follow-up of congenital toxoplasmosis. Lancet. 1986;1(8475): 254-256.
44. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114(2):136-144.
45. Abreu MT, Boni D, Belfort Jr R, et al. Toxoplasmose ocular em Venda Nova do Imigrante, ES, Brasil. Arq Bras Oftalmol. 1998;61:540-545.
46. Adams WH, Kindermann WR, Walls KW, Heotis PM. Toxoplasma antibodies and retinochoroiditis in the Marshall Islands and their association with exposure to radioactive fallout. Am J Trop Med Hyg. 1987;36(2):315-320.